These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18535600)

  • 21. [Combined idiopathic orbital inflammation and Graves' orbitopathy].
    Ciechanowski PP; Töteberg-Harms M; Pangalu A; Chaloupka K
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):466-7. PubMed ID: 22496035
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of retinal nerve fiber layer with optic nerve tracking optical coherence tomography in thyroid-associated orbitopathy.
    Forte R; Bonavolontà P; Vassallo P
    Ophthalmologica; 2010; 224(2):116-21. PubMed ID: 19729984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age influences the severity of Graves' ophthalmopathy.
    Lin MC; Hsu FM; Bee YS; Ger LP
    Kaohsiung J Med Sci; 2008 Jun; 24(6):283-8. PubMed ID: 18635413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?
    Gopinath B; Wescombe L; Nguyen B; Wall JR
    Orbit; 2009; 28(4):256-61. PubMed ID: 19839885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Beri M; Podhajsky P
    Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe Graves' ophthalmopathy accompanied by myasthenia gravis].
    Maeda K; Kume S; Nishio Y; Maeda S; Nishida Y; Suzuki M; Nakaguchi T; Kawabata T; Hashimoto O; Hisanaga T; Kashiwagi A; Yasuda H
    Rinsho Shinkeigaku; 2006 Apr; 46(4):266-9. PubMed ID: 16768093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
    Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
    Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy?
    Maurer E; Dănilă R; Dominguez E; Osei-Agymang T; Zielke A; Hassan I
    Chirurgia (Bucur); 2008; 103(3):291-5. PubMed ID: 18717277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalance of open angle glaucoma and ocular hypertension as a risk factor for primary open angle glaucoma in Wroclaw population. Wroclaw Epidemiology Study].
    Nizankowska MH; Kaczmarek R
    Klin Oczna; 2004; 106(1-2 Suppl):147-52. PubMed ID: 15510479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for vascular risk factors in glaucoma: the GVRF study.
    Zeyen T;
    Bull Soc Belge Ophtalmol; 2005; (298):53-60. PubMed ID: 16422222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroidectomy remains an effective treatment option for Graves' disease.
    Weber KJ; Solorzano CC; Lee JK; Gaffud MJ; Prinz RA
    Am J Surg; 2006 Mar; 191(3):400-5. PubMed ID: 16490555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center.
    Heinz C; Koch JM; Zurek-Imhoff B; Heiligenhaus A
    Ocul Immunol Inflamm; 2009; 17(4):243-8. PubMed ID: 19657977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.
    McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
    J Glaucoma; 2008 Aug; 17(5):372-7. PubMed ID: 18703947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures.
    ; Mourits MP; Bijl H; Altea MA; Baldeschi L; Boboridis K; Currò N; Dickinson AJ; Eckstein A; Freidel M; Guastella C; Kahaly GJ; Kalmann R; Krassas GE; Lane CM; Lareida J; Marcocci C; Marino M; Nardi M; Mohr Ch; Neoh C; Pinchera A; Orgiazzi J; Pitz S; Saeed P; Salvi M; Sellari-Franceschini S; Stahl M; von Arx G; Wiersinga WM
    Br J Ophthalmol; 2009 Nov; 93(11):1518-23. PubMed ID: 19028743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orbital MALT lymphoma in a patient with Graves' ophthalmopathy: a unique observation.
    Stark JJ; Newsom RW; Roman J; LaRocque JC; Richardson DW
    Cancer Invest; 2005; 23(7):593-5. PubMed ID: 16305986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid orbitopathy possibly predisposes to late-onset of periocular lymphoma.
    Nutting CM; Shah-Desai S; Rose GE; Norton AP; Plowman PN
    Eye (Lond); 2006 Jun; 20(6):645-8. PubMed ID: 16123786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent myopathy in patients with Graves' orbitopathy.
    Mensink HW; van Doorn PA; Paridaens D
    Orbit; 2009; 28(1):66-70. PubMed ID: 19229749
    [No Abstract]   [Full Text] [Related]  

  • 39. Selenium and the course of mild Graves' orbitopathy.
    Marcocci C; Kahaly GJ; Krassas GE; Bartalena L; Prummel M; Stahl M; Altea MA; Nardi M; Pitz S; Boboridis K; Sivelli P; von Arx G; Mourits MP; Baldeschi L; Bencivelli W; Wiersinga W;
    N Engl J Med; 2011 May; 364(20):1920-31. PubMed ID: 21591944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Whether lowering intraocular pressure is needed for thyroid associated ophthalmopathy with intraocular hypertension].
    Yang HS; Ye HJ
    Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):811-813. PubMed ID: 31715677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.